A 16 yr old boy with aggressive ca esophagus. DR Ayunga A.O Physician-Garisa PGH Associate Faculty Lecturer-UON Afya Bora Fellow in Global Health

Similar documents
ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

SETTING Fudan University Shanghai Cancer Center. RESPONSIBLE PARTY Haiquan Chen MD.

Minimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006

Aliu Sanni MD SUNY Downstate Medical Center August 16, 2012

Gastrointestinal pathology 2018 lecture 2. Dr Heyam Awad FRCPath

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

FTS Oesophagectomy: minimal research to date 3,4

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Controversies in management of squamous esophageal cancer

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS GASTROINTESTINAL (GI) PATHOLOGY LAB #1. January 06, 2012

Surgery for Gastric and Oesophageal Cancer

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Gastrointestinal Tract Cancer

Surgical strategies in esophageal cancer

Management of Esophageal Cancer: Evidence Based Review of Current Guidelines. Madhuri Rao, MD PGY-5 SUNY Downstate Medical Center


BRONCHOGENIC CARCINOMA CHALLENGES IN EVALUATION

Bronchogenic Carcinoma

Surgical Problems in Proximal GI Cancer Management Cardia Tumours Question #1: What are cardia tumours?

UCLA General Surgery Residency Program Rotation Educational Policy Goals and Objectives

Carcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY

ESOPHAGEAL CANCER. Dr. Paul Gardiner December 17, 2002 Discipline of Surgery Rounds

Esophageal Cancer. What is esophageal cancer?

Gastroesophageal Reflux Disease in Infants and Children

Radiology Pathology Conference

THORACIK RICK. Lungs. Outline and objectives Richard A. Malthaner MD MSc FRCSC FACS

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

CT PET SCANNING for GIT Malignancies A clinician s perspective

Lung Cancer Case Study

A 21 year old woman with a rapidly growing mass on palate. Dr. Elizabeth Bigger and Dr. Memory Bvochora 18 March 2015

Respiratory Interactive Session. Elaine Borg

Safe Answers For The American Board of Surgery Certifying Exam & Recertifying Exam

Oesophageal Cancer: The Image after Surgery

Oesophageal Cancer: The Image after Surgery

Hong Kong Society of Upper Gastrointestinal Surgeons CLINICAL MEETING 29 NOV 2012

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

Adenocarcinoma of gastro-esophageal junction - Case report

CASE REPORTS. Giant Esophagus. An Unusual Case of Massive Idiopathic Hypertrophy

International Journal of Medical Science and Health Research

Lung Cancer - Suspected

Abstracting Hematopoietic Neoplasms

Esophageal cancer. What is esophageal cancer? Esophageal cancer is a disease in which malignant (cancer) cells form in the tissues of the esophagus.

Patient information for Mediastinoscopy

Esophageal Bypass Using a Gastric Tube for a Malignant Tracheoesophageal/ Bronchoesophageal Fistula: A Report of 4 Cases

Clinical Pathological Conference. Malignant Melanoma of the Vulva

Thoracic Surgery; An Overview

Esophageal Cancer. Understanding your diagnosis cancer.ca

Chapter 14: Training in Radiology. DDSEP Chapter 1: Question 12

Acquired pediatric esophageal diseases Imaging approaches and findings. M. Mearadji International Foundation for Pediatric Imaging Aid

B. Cystic Teratoma: Refer to virtual microscope slide p_223 ovary, teratoma and compare to normal virtual microscope slide 086 ovary.

The Learning Curve for Minimally Invasive Esophagectomy

Gastroesophageal reflux disease Principles of GERD treatment Treatment of reflux diseases GERD

Citywide Infectious Disease Conference. March 27 th, 2018

Case conference. Welcome Dr. Lawrence Tierney

Esophageal Cancer. Source: National Cancer Institute

Back to Basics: What Imaging Test should I order? Jeanne G. Hill, M.D. Pediatric Radiology Medical University of South Carolina

Determining the Optimal Surgical Approach to Esophageal Cancer

Adam J. Hansen, MD UHC Thoracic Surgery

Cervical Lymphadenopathy. Diagnosis and Management

Case Presentation Surgery Grand Round. Amid Keshavarzi, MD UCHSC 4/9/2006

Cancer of Unknown Primary (CUP) Protocol

THE CONNECTIVE TISSUE AND EPITHELIUM

Chief Complain. For chemotherapy

Esophageal Perforation

CARCINOMA OF ESOPHAGUS PERFORATING THE AORTA*

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

PLACE LABEL HERE. Radiation Therapy Oncology Group Phase II - SBRT - Medically Inoperable I /II NSCLC Follow-up Form. RTOG Study No.

OPEN ACCESS TEXTBOOK OF GENERAL SURGERY

Oesophagogastric Cancer The Patient s Pathway

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management

Myogenic Control. Esophageal Motility. Enteric Nervous System. Alimentary Tract Motility. Determinants of GI Tract Motility.

Esophageal Motility. Alimentary Tract Motility

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

David Markowitz, MD. Physicians and Surgeons

- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer

with Distal Obstruction

Management of Neck Metastasis from Unknown Primary

Jejunostomy after oesophagectomy, how and why I do it

Peptic ulcer disease Disorders of the esophagus

9/18/2015. Disclosures. Objectives. Dysphagia Sherri Ekobena PA-C. I have no relevant financial interests to disclose I have no conflicts of interest

Esophageal Cancer Initially Thought to be Accompanied by a Solitary Metastasis to an Intrathoracic Paraaortic Lymph Node

Larry Tan, MD Thoracic Surgery, HSC. Community Cancer Care Educational Conference October 27, 2017

Robotic-assisted McKeown esophagectomy

PDF created with pdffactory Pro trial version

Appendix 1: Regional Lymph Node Stations for Staging Esophageal Cancer

A 73 year old man, presents with anaemia. Describe the CT scan. Should see primary gastric cancer,ascites and liver secondary

A Case of Pediatric Plasma Cell Granuloma

CASE DISCUSSION ON GASTRIC CANCER BASED ON ESMO GUIDELINES

Medicinae Doctoris. One university. Many futures.

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

7/20/2017. Esophageal Cancer: A Less Common But Deadly Cancer. Objectives. Disclosure Statement NYNPA Conference October Saratoga New York

Lung Cancer Imaging. Terence Z. Wong, MD,PhD. Department of Radiology Duke University Medical Center Durham, NC 9/9/09

Adjuvant therapy for thyroid cancer

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Professor, Department of Endoscopic Diagnostic and Therapeutics, Chiba University School of Medicine

Respiratory system. Applied Anatomy &Physiology

Limited en bloc Resection of the Gastroesophageal Junction with Isoperistaltic Jejunal Interposition

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO

Transcription:

A 16 yr old boy with aggressive ca esophagus DR Ayunga A.O Physician-Garisa PGH Associate Faculty Lecturer-UON Afya Bora Fellow in Global Health

Cancer of esophagus in a 16yr old Y.N 16 yr old boy unwell for the past 3 yrs with on and off dyspepsia and hurtburn He was being managed for peptic ulcer disease. Pt presented to our hospital on the 28/7/12 with c/o - of retrosternal and epigastric pain -postprandial vomiting, -hematemesis, - progressive dysphagia. O/E patient was sick looking,wasted with epigastric tenderness with no palpable masses or organomegally

Investigations done: Investigations 1.barium swallow 1yr back that demonstrated a distal 1/3 oesophageal stricture. 2.FHG which was normal. 3.h.pylori test negative.

Patient was referred to KNH for an OGD,biopsy and CT scan which were done on 25/8/12 and showed : OGD: stricture at 30cm blocking lumen. Biopsy: necrotic tumor disposed in nests of very pleomorphic squamous cells with a diagnosis of poorly differentiated SCC. CT scan: malignant stricture of esophagus at T5-T10 with proximal dilatation,small subcentimetre mediastinal nodes.

Pt advised to have surgery but could not afford at the time and presented again on 17/10/12 with vomiting,inability to swallow and hotness of body. Patient was put on intravenous fluids and referred to Nyeri for surgical management-ivor lewis esophagectomy was done on 6/11/12. Tumour was resected with 3cm free margin and was transfused 6 pints of blood. Pt admitted in ICU post-op and developed ARF but regained normal RF after 3 days of Rx. Discharged while he was able to feed and with normal bowel movements.

Patient was brought back to Garissa PGH 30 days postop for palliative management. He was was markedly wasted with bilateral lower limb pitting edema upto midleg and had a right chest tube draining purulent fluid. Patient developed left sided empyema thoracis 2 nd day post admission which was drained by a chest tube. right chest tube was removed but 6 th post admission day patient developed a right pneumothorax and a right chest tube was reinserted.

Further tests after readmission Investigations done: FHG: WBC 12.1 with granulocytes 88%,HB 13.9,MCV and MCH normal,plt 207. Electrolytes: k 3.59,Na 131.4,Cl 104.1. Creatinine:239.52. LFT:AST 41.75,ALP 346.4,GGT 181.05,Albumin 1.71,total protein 5.49,Direct bilirubin 6.56,total bilirubin 28.7. Pleural fluid M/C/S: gram stain heavy growth of s.aureus with many intracellular G-ve diplococcic sensitive to linezolid and resistant to PenG,oxacillin,azithromycin and sporfloxacin.

Patient was put on high protein diet,sc heparin 5000iu BD,IV flagyl and IV ceftriaxone. patient was doing well in the ward with mild respiratory distress. On 17/12/12 patient developed severe respiratory distress with a left chest tube insitu,xray done showed bilateral pneumothorax,patient was put on oxygen via nasal prongs(relatives declined via mask). family declined chest tube reinsertion on the right side. On th 18/12/12 morning patient was certified dead.

Discussion Esophageal cancer usually develops in persons between 50 and 70 years of age. M:F 3:1. There are two histologic types: squamous cell carcinoma and adenocarcinoma. Chronic alcohol and tobacco use are strongly associated with an increased risk of squamous cell carcinoma. Other risks are Tylosis, achalasia, caustic-induced esophageal stricture, and other head and neck cancers.

SCC has a high incidence in certain regions of China and Southeast Asia. 50% of all cases occur in the distal third of the esophagus. Adenocarcinoma is more common in whites. The majority of adenocarcinomas develop as a complication of Barrett's metaplasia due to chronic gastroesophageal reflux. Most adenocarcinomas arise in the distal third of the esophagus

Symptoms Most pts with esophageal cancer present with advanced, incurable disease. Over 90% have solid food dysphagia, which progresses over weeks to months. Odynophagia is sometimes present. Significant weight loss is common. Local tumor extension into the tracheobronchial tree may result in a TOF, characterized by coughing on swallowing or pneumonia.

Chest or back pain suggests mediastinal extension. Recurrent laryngeal involvement may produce hoarseness. Physical examination is often unrevealing. The presence of supraclavicular or cervical lymphadenopathy or of hepatomegaly implies metastatic disease.

investigations Lab-Non specific Anaemia of chronic disease Hypoalbuminemia due to malnutrion CXR-may show adenopathy, a widened mediastinum, pulmonary or bony metastases, or signs of TOF. Barium esophagiogram fisrt study followed by OGD with biopsy

DDX Achalasia Peptic stricture Adenocarcinoma of the gastric cardia with esophageal extension Benign tumours

Staging Done to guide therapy CT scan of chest and liver to exclude metastases,lympadenopathy or tumour extension Two most important predictors of poor survival are lymph node involvement and adjacent mediastinal spread.

Treatment Depends on the stage IIIB- palliation-combination radiation and chemotherapy